Holen Sie sich die Stockscreener-App
6.57
0.46%
0.03
Handel nachbörslich:
6.44
-0.13
-1.98%
Schlusskurs vom Vortag:
$6.54
Offen:
$6.47
24-Stunden-Volumen:
65,219
Relative Volume:
0.33
Marktkapitalisierung:
$52.32M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-10.11
EPS:
-0.65
Netto-Cashflow:
$-45.93M
1W Leistung:
+2.18%
1M Leistung:
-12.98%
6M Leistung:
-38.53%
1J Leistung:
-80.21%
1-Tages-Spanne:
$6.33
$6.94
1-Wochen-Bereich:
$6.22
$7.06
52-Wochen-Spanne:
$3.436
$34.39
Biodesix Inc Stock (BDSX) Company Profile
Firmenname
Biodesix Inc
Sektor
Branche
Telefon
303-417-0500
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Vergleichen Sie BDSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
6.57 | 52.32M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
556.22 | 210.82B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
215.05 | 151.17B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
628.54 | 50.22B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
143.36 | 40.60B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
216.47 | 37.10B | 15.70B | 1.24B | 2.01B | 6.9036 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-26 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-13 | Eingeleitet | TD Cowen | Buy |
| 2024-05-03 | Eingeleitet | Lake Street | Buy |
| 2021-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Eingeleitet | BTIG Research | Buy |
| 2020-11-23 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Biodesix Inc. recovery potential after sell off2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - newser.com
Biodesix to Showcase R&D Innovations and Collaborations at 2025 AMP Annual Meeting in Boston - Quiver Quantitative
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting - MarketScreener
Biodesix (NASDAQ: BDSX) plans AMP 2025 workshop on NGS, ddPCR and mass spec advances - Stock Titan
Institutional scanner results for Biodesix Inc.July 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com
Will breakout in Biodesix Inc. lead to full recoveryJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
Is Biodesix Inc. stock a good choice for value investorsTreasury Yields & Stepwise Trade Signal Guides - newser.com
Can Biodesix Inc. stock rebound after recent weaknessBear Alert & Detailed Earnings Play Strategies - newser.com
Technical signs of recovery in Biodesix Inc.2025 Analyst Calls & Entry Point Strategy Guides - newser.com
Order flow analysis tools used on Biodesix Inc.Forecast Cut & Growth-Oriented Investment Plans - newser.com
Biodesix CEO rings Nasdaq’s closing bell - BizWest
Louisville company rings Nasdaq bell after regaining listing compliance - The Business Journals
Can Biodesix Inc. stock outperform in 2025 bull marketWeekly Investment Summary & Fast Exit and Entry Trade Guides - newser.com
Will Biodesix Inc. stock reach all time highs in 2025July 2025 Price Swings & Daily Growth Stock Investment Tips - Fundação Cultural do Pará
Biodesix, Inc. Rings the Closing Bell - Nasdaq
Is Biodesix Inc. stock a bargain at current levelsPortfolio Risk Summary & High Yield Equity Trading Tips - newser.com
How risky is Biodesix Inc. stock nowPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Best data tools to analyze Biodesix Inc. stockGold Moves & Safe Capital Investment Plans - newser.com
Is Biodesix Inc. a candidate for recovery playJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com
Regression analysis insights on Biodesix Inc. performancePortfolio Update Report & Expert Curated Trade Ideas - newser.com
Published on: 2025-10-27 22:09:06 - newser.com
Published on: 2025-10-27 19:23:02 - newser.com
Biodesix Expands Bio-Rad Partnership in Cancer Diagnostics - Technology Networks
How to manage a losing position in Biodesix Inc.2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com
Finanzdaten der Biodesix Inc-Aktie (BDSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biodesix Inc-Aktie (BDSX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SCHULER JACK W | Director |
Sep 17 '25 |
Buy |
6.04 |
15,317 |
92,571 |
1,235,644 |
| SCHULER JACK W | Director |
Sep 18 '25 |
Buy |
6.17 |
3,056 |
18,854 |
1,238,700 |
| SCHULER JACK W | Director |
Aug 29 '25 |
Buy |
0.43 |
3,488,372 |
1,500,000 |
24,406,546 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Aug 13 '25 |
Sale |
0.42 |
988 |
411 |
250,794 |
| Hutton Scott | President & CEO |
Aug 13 '25 |
Sale |
0.42 |
3,772 |
1,570 |
728,824 |
| O'Kane Kieran | Chief Commercial Officer |
Aug 13 '25 |
Sale |
0.42 |
476 |
198 |
140,065 |
| Pestano Gary Anthony | Chief Development Officer |
Aug 13 '25 |
Sale |
0.42 |
442 |
184 |
157,878 |
| Vazquez Chris | Chief Accounting Officer |
Aug 13 '25 |
Sale |
0.42 |
228 |
95 |
18,375 |
| SCHULER JACK W | Director |
May 16 '25 |
Buy |
0.27 |
4,000,000 |
1,070,000 |
20,194,935 |
| SCHULER JACK W | Director |
May 19 '25 |
Buy |
0.34 |
723,239 |
246,624 |
20,918,174 |
0.55%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):